PetMed Express D/B/A 1-800-Petmeds Announces Record Second Quarter Financial Results
Oct 23, 2017 12:01 pm UTC| Business
Second Quarter Net Income Increased 79%Second Quarter Sales Increased 10%Second Quarter Online Sales Increased 12% DELRAY BEACH, Fla., Oct. 23, 2017 -- PetMed Express, Inc. (NASDAQ:PETS) today announced its...
Provant Chief Information Officer Tom Basiliere to Speak on Mitigating Data Breach Risks
Oct 23, 2017 12:01 pm UTC| Business
EAST GREENWICH, R.I., Oct. 23, 2017 -- As part of a webinar series sponsored by Compass IT Compliance, Tom Basiliere, CIO for Provant and its parent company Hooper Holmes (OTCQX:HPHW), is presenting a session on...
Flexera to Present on Open Source for Executives and Developers at All Things Open 2017
Oct 23, 2017 12:01 pm UTC| Business
ITASCA, Ill., Oct. 23, 2017 -- WHAT:Flexera will be presenting at All Things Open 2017 in Raleigh, North Carolina October 23 - 24. All Things Open is the largest “open” technology event on the East Coast, gathering...
Oct 23, 2017 12:01 pm UTC| Business
Data Support Clinical Evaluation of Gemcabene as a Potential Treatment For NAFLD/NASH Clinical Trial in NAFLD/NASH Planned to Begin 4Q-2017 LIVONIA, Mich., Oct. 23, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a...
Jounce Therapeutics Appoints Luis A. Diaz, Jr., M.D., to its Board of Directors
Oct 23, 2017 12:01 pm UTC| Business
CAMBRIDGE, Mass., Oct. 23, 2017 -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient...
Skybox Security and SecurityMatters Join Forces to Secure Industrial Networks
Oct 23, 2017 12:00 pm UTC| Business
SAN JOSE, Calif., Oct. 23, 2017 -- Skybox™ Security, a global leader in cybersecurity management, announced today integration with SecurityMatters, a provider of passive, automated network monitoring for industrial...
Soleno Therapeutics Regains Compliance with NASDAQ Listing Requirements
Oct 23, 2017 12:00 pm UTC| Business
REDWOOD CITY, Calif., Oct. 23, 2017 -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced it received a...